Literature DB >> 22461634

Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer.

Lucas Leite Cunha, Elaine Cristina Morari, Ana Carolina Trindade Guihen, Daniela Razolli, Renê Gerhard, Suely Nonogaki, Fernando Augusto Soares, José Vassallo, Laura Sterian Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22461634     DOI： 10.1530/ERC-11-0285

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  11 in total

1.  BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.

Authors:  Trevor E Angell; Melissa G Lechner; Julie K Jang; Adrian J Correa; Jonathan S LoPresti; Alan L Epstein
Journal:  Thyroid       Date:  2014-07-15       Impact factor: 6.568

2.  The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Authors:  Yun Zhang; Jiaqi Dai; Tingting Wu; Nailin Yang; Zhiqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-12       Impact factor: 4.553

3.  MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.

Authors:  Trevor E Angell; Melissa G Lechner; Julie K Jang; Jonathan S LoPresti; Alan L Epstein
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

4.  FOXE1 association with differentiated thyroid cancer and its progression.

Authors:  Marissa Penna-Martinez; Friederike Epp; Heinrich Kahles; Elizabeth Ramos-Lopez; Nora Hinsch; Martin-Leo Hansmann; Ivan Selkinski; Frank Grünwald; Katharina Holzer; Wolf O Bechstein; Stefan Zeuzem; Christian Vorländer; Klaus Badenhoop
Journal:  Thyroid       Date:  2014-01-29       Impact factor: 6.568

Review 5.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

6.  Clinical utility of KAP-1 expression in thyroid lesions.

Authors:  Mariana Bonjiorno Martins; Marjory Alana Marcello; Elaine Cristina Morari; Lucas Leite Cunha; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Endocr Pathol       Date:  2013-06       Impact factor: 3.943

7.  CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.

Authors:  Mariana Bonjiorno Martins; Marjory Alana Marcello; Fernando de Assis Batista; Lucas Leite Cunha; Elaine Cristina Morari; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  J Immunol Res       Date:  2014-11-04       Impact factor: 4.818

Review 8.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

9.  The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status.

Authors:  Lucas Leite Cunha; Guilherme Augusto Barcelos Domingues; Elaine Cristina Morari; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Cancer Cell Int       Date:  2021-07-20       Impact factor: 5.722

Review 10.  Update on Fundamental Mechanisms of Thyroid Cancer.

Authors:  Alessandro Prete; Patricia Borges de Souza; Simona Censi; Marina Muzza; Nicole Nucci; Marialuisa Sponziello
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-13       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.